What does Corum Pharma do?
CORUM PHARMA specializes in the development and commercialization of innovative pharmaceutical products. The company focuses on niche markets and offers a range of solutions in the fields of oncology, neurology, and pain management. With a commitment to improving patient outcomes, CORUM PHARMA invests in research and development to bring new therapies to market.
- Sectors
- Holding companies
- Activities
- Signals
-
Poor liquidityPoor liquidity 0.22
The current ratio is below 1: may be insufficient to cover short-term debt.
High social debt vs. personnel costsHigh social debt vs. personnel costs 195.3%Social debts are a high share of personnel costs, which may indicate social security arrears.
ProfitableProfitable € 67KThe company reported a positive net result in the latest financial year.
Strong equityStrong equity € 1.74MStrong equity provides a buffer against setbacks.
Low riskLow risk 74.7%Good solvency (> 30%) points to long-term financial stability.
Positive cashflowPositive cashflow € 80KPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 102KPositive EBITDA: operating activities are profitable.
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2026
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
105K
|
€
112K
|
€
119K
|
€
108K
|
|
|
€
102K
|
€
112K
|
€
118K
|
€
108K
|
|
|
€
67K
|
€
72K
|
€
80K
|
€
83K
|
|
|
€
1.74M
|
€
1.67M
|
€
1.60M
|
€
1.52M
|
|
|
74.66%
|
71.55%
|
67.48%
|
65.90%
|
|
|
€
590K
|
€
664K
|
€
770K
|
€
786K
|
|
|
€
5K
|
€
22K
|
€
26K
|
€
22K
|
Publications 1
All publicationsFrequently asked questions
Answers to the most common questions about Corum Pharma, based on official government data and the filed annual accounts.
What is the VAT number of Corum Pharma?
The VAT number of Corum Pharma is BE0763.652.492.
When was Corum Pharma established?
Corum Pharma was founded in 15-02-2021.
What is the official address of Corum Pharma?
The official address of Corum Pharma is Heirweg 144 A Wielsbeke 8710.
What is the legal form of Corum Pharma?
The juridical form of Corum Pharma is Private limited company (BV/SRL).
What is the annual revenue of Corum Pharma?
The 2026 accounts of Corum Pharma do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
What does Corum Pharma do?
CORUM PHARMA specializes in the development and commercialization of innovative pharmaceutical products. The company focuses on niche markets and offers a range of solutions in the fields of oncology, neurology, and pain management. With a commitment to improving patient outcomes, CORUM PHARMA invests in research and development to bring new therapies to market.
Is Corum Pharma a reliable company?
Corum Pharma is a registered Rechtspersoon with company number 0763.652.492 and can be verified through the official CBE database.
What is the credit limit of Corum Pharma?
The estimated credit limit of Corum Pharma is €161,699.
Is Corum Pharma still active?
Corum Pharma currently has the status "Normal situation" and is active.